-
CT radiomics compared to a clinical model for predicting checkpoint inhibitor treatment outcomes in patients with advanced melanoma2023 European Journal of Cancer article Medicine Radiomics and Machine Learning in Medical Imaging Open access
Laurens S. ter Maat, Isabella A.J. van Duin, Sjoerd Geert Elias, Tim Leiner, Joost J.C. Verhoeff, E.R.A.N. Arntz, +17 more
11citations -
The survival disparity between children and adolescents and young adults (AYAs) with Ewing sarcoma in the Netherlands did not change since the 1990s despite improved survival: A population-based study
Maya Schulpen, Lianne Haveman, Lizz van der Heijden, Suzanne E. J. Kaal, Jos A. M. Bramer, Raquel Dávila Fajardo, +11 more
11citations -
Patient-reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after treatment with imatinib in INTRIGUE, a phase 3, open-label study2023 European Journal of Cancer article Medicine Gastrointestinal Tumor Research and Treatment Open access
Hans A. J. Gelderblom, Robin L. Jones, Jean‐Yves Blay, Suzanne George, Margaret von Mehren, John Raymond Zalcberg, +22 more
11citations -
Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia—results of a double-blind, randomised controlled trial with cross-over design
Annelienke M. van Hulst, Erica L T van den Akker, Emma J. Verwaaijen, Marta F. Fiocco, Niki Rensen, Raphaële R. L. van Litsenburg, +7 more
10citations -
Differences in treatment and survival of older patients with operable breast cancer between the United Kingdom and the Netherlands – A comparison of two national prospective longitudinal multi-centre cohort studies2022 European Journal of Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Willeke G van der Plas-Krijgsman, Jenna L. Morgan, Nienke A. de Glas, Anna Z. de Boer, Charlene Martin, Geoffrey R. Holmes, +13 more
10citations -
Phase II trial of atezolizumab (Anti-PD-L1) in the treatment of relapsed/refractory IIB/IVB mycosis fungoides/Sézary syndrome patients after previous systemic treatment. EORTC-1652-CLTG “PARCT”2025 European Journal of Cancer article Medicine Cutaneous lymphoproliferative disorders research Open access
Rudolf Stadler, Gabriele Roccuzzo, Pablo Luis Ortiz-Romero, Martine Bagot, Pietro Quaglino, Emmanuella Guenova, +15 more
10citations -
Model soups improve performance of dermoscopic skin cancer classifiers2022 European Journal of Cancer article Medicine Cutaneous Melanoma Detection and Management Open access
Roman Christoph Maron, Achim Hekler, Sarah Haggenmüller, Christof V. Kalle, Jochen Sven Utikal, Verena Alexandra Müller, +27 more
9citations -
The impact of isolated local recurrence on long-term outcome in early-breast cancer patients after breast-conserving therapy2021 European Journal of Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Conny Vrieling, Samson Yaekob Assele, Lotte C. Moser, Nicolas Sauvé, Saskia Litière, Alain Fourquet, +5 more
9citations -
Association between endocrine therapy and cognitive decline in older women with early breast cancer: Findings from the prospective CLIMB study2023 European Journal of Cancer article Medicine Cancer-related cognitive impairment studies Open access
Joosje C. Baltussen, Marloes G.M. Derks, Annelieke A. Lemij, Nienke A. de Glas, Marta F. Fiocco, E. Linthorst-Niers, +10 more
9citations -
Subcutaneous versus intravenous amivantamab, both in combination with lazertinib, in refractory EGFR-mutated non-small cell lung cancer: Patient satisfaction and resource utilization results from the PALOMA-3 study
Mariam Alexander, Ying Cheng, Se-Hoon Lee, Antonio Passaro, Alexander I. Spira, Byoung Chul Cho, +25 more
8citations -
Imaging standardisation in metastatic colorectal cancer: A joint EORTC-ESOI-ESGAR expert consensus recommendation2022 European Journal of Cancer article Medicine Radiomics and Machine Learning in Medical Imaging Open access
Marcus Unterrainer, Christophe M. Deroose, Ken Herrmann, Markus Hermann Moehler, Lennart Blomqvist, Roberto Cannella, +27 more
8citations -
Understanding how a personalized risk prediction tool (VALUE-PERSARC) supports informed treatment decisions of soft-tissue sarcomas patients in daily clinical practice – A mixed methods study2024 European Journal of Cancer article Health Professions Patient-Provider Communication in Healthcare Open access
Anouk A. Kruiswijk, Ellen G. Engelhardt, Lisa A. E. Vlug, Robert J P van de Wal, Yvonne M. Schrage, Rick L. Haas, +3 more
7citations -
Efficacy of encorafenib plus binimetinib in patients with BRAF-mutated melanoma brain metastases: Results from the Dutch Melanoma Treatment Registry2025 European Journal of Cancer article Biochemistry, Genetics and Molecular Biology Melanoma and MAPK Pathways Open access
Karijn P.M. Suijkerbuijk, Maureen J.B. Aarts, Franchette W.P.J. van den Berkmortel, C.U. Blank, Willeke A.M. Blokx, Marye J. Boers‐Sonderen, +13 more
7citations -
Impact of age on safety of Busulfan-Melphalan followed by autologous hematopoietic stem-cell transplantation versus standard chemotherapy in the patients of the EURO-E.W.I.N.G. 99 and Ewing 2008 clinical trials
Xavier Choderlos de Laclos, Séverine Risbourg, Bernadette M. D. Brennan, François Bertucci, Nathalie Gaspar, Hans A. J. Gelderblom, +15 more
7citations